Abstract
Importance: Chronic myeloid leukemia (CML) has an annual incidence of 2 cases per 100 000 people and is newly diagnosed in approximately 9300 individuals per year in the US. Approximately 150 000 people in the US and 5 million worldwide have CML. Observations: Chronic myeloid leukemia is a myeloproliferative neoplasm characterized by the presence of the Philadelphia chromosome, which is defined by the BCR::ABL1 oncogene that develops after fusion of the ABL1 proto-oncogene to the constitutively active BCR gene. Approximately 90% of people with CML present with an indolent chronic phase of CML, defined as blasts of less than 10% in the blood or bone marrow, absence of extramedullary evidence of leukemia,…
Citation impact
74
total citations
- FWCI
- 96.14
- Percentile
- 100%
- References
- 80
Citations per year
Authors
2Topics & keywords
Topics
Keywords
- Medicine
- Dasatinib
- Nilotinib
- Imatinib
- Bosutinib
- Philadelphia chromosome
- Myeloid leukemia
- Imatinib mesylate
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.